| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 4/A | Open Document | Open Filing | AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 25 Apr 2022 | 20 Apr 2022 | 001-39802 |
| 4 | Open Document | Open Filing | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 21 Apr 2022 | 20 Apr 2022 | 333-170738 |
| 3 | Open Document | Open Filing | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 21 Sep 2021 | 10 Sep 2021 | 001-39802 |
| 4 | Open Document | Open Filing | PRIMARY DOCUMENT | 10 Feb 2017 | 30 Jan 2017 | 001-35119 |
| SC 13D/A | Open Document | Open Filing | SC 13D/A | 10 Feb 2017 | ||
| SC 13D/A | Open Document | Open Filing | SC 13D/A | 02 Feb 2017 | ||
| SC 13D/A | Open Document | Open Filing | OCERA THERAPEUTICS, INC. - AMEND. NO. 2 | 17 Feb 2016 | ||
| SC 13D/A | Open Document | Open Filing | OCERA THERAPEUTICS, INC. - AMEND. NO. 1 | 13 Feb 2015 | ||
| SC 13D | Open Document | Open Filing | SC 13D | 25 Jul 2013 | ||
| 4/A | Open Document | Open Filing | OWNERSHIP DOCUMENT | 17 Jul 2013 | 15 Jul 2013 | 001-35119 |
| SC 13G/A | Open Document | Open Filing | SC 13G/A | 12 Feb 2013 | ||
| SC 13G | Open Document | Open Filing | SC 13G | 14 Feb 2012 |